Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17804858 | 1.00 | ALOX5 (0.42) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17804904 | 0.99 | ALOX5 (0.41) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17805023 | 0.98 | ALOX5 (0.45) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17805120 | 0.97 | ALOX5 (0.44) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17805154 | 0.97 | ALOX5 (0.44) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17805018 | 0.97 | ALOX5 (0.44) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17804950 | 0.97 | ALOX5 (0.43) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17804877 | 0.97 | ALOX5 (0.46) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17805145 | 0.97 | ALOX5 (0.46) | ALOX5PRKDCKDM4EMEN1LMNA | |
| SCHEMBL17805015 | 0.97 | ALOX5 (0.46) | ALOX5PRKDCKDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756275-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| EP-3029023-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2016-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10756275-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment | CHRM1, L1CAM, ESR1 | ALOX5 1925/4885PRKDC 4847/4885KDM4E 1907/4885 |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | CHRM1, L1CAM, ESR1 | ALOX5 1925/4885PRKDC 4847/4885KDM4E 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.